APA

Morel O., Hugel B., Jesel L., Mallat Z., Lanza F., Douchet M., Zupan M., Chauvin M., Cazenave J., Tedgui A., Freyssinet J. & Toti F. (20050302). Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. : Journal of thrombosis and haemostasis : JTH.

Chicago

Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet M-P, Zupan M, Chauvin M, Cazenave J-P, Tedgui A, Freyssinet J-M and Toti F. 20050302. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. : Journal of thrombosis and haemostasis : JTH.

Harvard

Morel O., Hugel B., Jesel L., Mallat Z., Lanza F., Douchet M., Zupan M., Chauvin M., Cazenave J., Tedgui A., Freyssinet J. and Toti F. (20050302). Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. : Journal of thrombosis and haemostasis : JTH.

MLA

Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet M-P, Zupan M, Chauvin M, Cazenave J-P, Tedgui A, Freyssinet J-M and Toti F. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. : Journal of thrombosis and haemostasis : JTH. 20050302.